Skip to content

Systems Analysis and Improvement Approach for Prevention of MTC HIV Transmission

Scaling up the Systems Analysis and Improvement Approach for Prevention of Mother-to-Child HIV Transmission in Mozambique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03425136
Acronym
SAIA-SCALE
Enrollment
36
Registered
2018-02-07
Start date
2018-02-01
Completion date
2022-03-31
Last updated
2022-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

Prevention of Mother-to-Child HIV Transmission, HIV, PMTCT

Brief summary

Optimizing the prevention of mother-to-child HIV transmission cascade minimizes drop offs from one step to the next to maximize the benefits of antiretroviral therapy on maternal health and pediatric survival, growth, and development. This proposal scales-up a health systems intervention (the systems analysis and improvement approach - SAIA) that packages systems engineering methods (including cascade analysis, flow mapping, and continuous quality improvement) and was previously shown to be effective in improving the prevention of mother-to-child HIV transmission cascade. By spreading the SAIA through routine district management structures, and studying the implementation process, this study will build evidence on how to achieve rapid, sustainable and scalable improvements in services that can dramatically improve population health in resource limited countries.

Detailed description

Despite significant increases in global health investment and the availability of low-cost, efficacious interventions designed to prevent mother to child HIV transmission (PMTCT) in low and middle income countries with high HIV burden, the translation of these scientific advances into effective delivery strategies has been slow, uneven and incomplete. As a result, pediatric HIV infection remains largely uncontrolled. The introduction of the Option B+ strategy - where HIV-infected pregnant women rapidly initiate lifelong antiretroviral therapy (ART) independent of disease status - has the potential to dramatically reduce HIV transmission during pregnancy, birth and the breastfeeding period, and as a result, it has been scaled up throughout high HIV burden countries in sub-Saharan Africa. Despite these significant investments to scale-up Option B+, results have been poor, with high rates of loss to follow-up and low viral suppression, leading to continued HIV transmission to children and HIV-associated morbidity among mothers. A previous research project (the Systems Analysis and Improvement Approach - or SAIA - cluster randomized trial) demonstrated that a package of systems engineering tools including cascade analysis, process mapping, and continuous quality improvement, was effective at improving flow through the PMTCT cascade across three sub-Saharan African countries. The overall goal of this application is to develop a model to deliver the SAIA intervention (SAIA-SCALE) that is led by district maternal and child health (MCH) supervisors (rather than research nurses), to serve as a foundation for national scale-up. We propose to implement the SAIA intervention in all districts in one province in Mozambique using MCH supervisors as disseminating agents, who will implement SAIA in subordinate health facilities. Using a three-year phased-in design, 12 districts will be randomly allocated into three implementation waves, and a mixed-methods evaluation will be used to assess the impact of the intervention. Our specific aims are to: Aim 1: Develop an effective district-based dissemination and implementation strategy for the SAIA intervention (SAIA-SCALE), using the RE-AIM model to evaluate the program's Reach, Effectiveness, Adoption, Implementation, and Maintenance; and Aim 2: Using activity based micro-costing and mathematical models of HIV transmission, estimate the budget and program impact from the payer perspective to scale-up the SAIA intervention compared to the standard of care. The results of this implementation research are expected to generate knowledge of global health significance, and by providing a real-world implementation model for the SAIA intervention and programmatically relevant information, is designed to lead to rapid policy translation for future scale-up in countries with high burden of HIV and weak PMTCT delivery systems.

Interventions

Five-step systems analysis and iterative improvement cycles applied by district maternal and child health supervisors to subordinate health facilities providing prevention of mother-to-child HIV transmission services at the facility level.

Sponsors

Ministry of Health, Mozambique
CollaboratorOTHER_GOV
Health Alliance International
CollaboratorOTHER
Fred Hutchinson Cancer Center
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

A three-wave stepped-wedge (phased-in) cluster randomized trial, with districts as the unit of randomization (and outcomes assessed at the clinic/individual level within each district)

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

• Woman/infant pair attending pMTCT and linked pediatric HIV screening and treatment services at a public sector health facility

Exclusion criteria

• None

Design outcomes

Primary

MeasureTime frameDescription
Maternal retention in care, evaluated using clinic registry data6-months post ART initiationWomen retained in care (picked up their 6-month pharmacy refill within 15 days of scheduled pickup)

Secondary

MeasureTime frameDescription
Early Infant Diagnosis for HIV, evaluated using clinic registry datawithin 8 weeks of birthProportion of HIV-exposed infants tested for HIV (PCR) within 8 weeks of birth
Facility Delivery, evaluated using clinic registry dataAt birthProportion of HIV-infected women enrolled in antenatal care with a facility delivery
Maternal viral load assessment, evaluated using clinic registry dataWithin 1 month of delivery (birth)Proportion of women on ART with viral load assessment
Viral Suppression, evaluated using clinic registry dataWithin 1 months of deliveryProportion of viral load samples with undetectable viral load (\<20 copies/mL)
Mother-to-Child HIV Transmission Rate, evaluated using clinic registry data6 months postpartumProportion of HIV-exposed infants testing positive for HIV
Maternal ART Adherence, evaluated using clinic registry dataAt 3 and 6 months post ART initiationProportion of expected ART medicines picked up at study clinics

Countries

Mozambique

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026